[1] | Alekshun, M., N, and Levy, S., B (2007): Molecular Mechanisms of Antibacterial Multidrug Resistance. Cell 128, 1037-1050. |
[2] | Bager, F., and Helmuth, R. (2001): Epidemiology of resistance to quinolones in SalmonellaVet. Res. 32 (2001) 285-290. Vet.Res 32, 285-290. |
[3] | Cammie, F., and Miller, S. (2000): Salmonellosis, pp. 970-975. In E. Brauneald, A. Faucl, D. La[ser, S. Hauser, D. Longo, and J. Jameson (Eds): Principle of internal medicine. 15th,ed, Churchil Living Stone, UK. |
[4] | Carattoli, A. (2003): Plasmid-mediated antimicrobial resistance in Salmonella enterica. CurrIssues Mol Biol 5, 113-22. |
[5] | Carattoli, A., Miriagou, V., Bertini, A., Loli, A., Colinon, C., Villa, L., Whichard, J. M., and Rossolini, G. M. (2006): Replicon typing of plasmids encoding resistance to newer beta-lactams. Emerg Infect Dis 12, 1145-8. |
[6] | Collis, C., Mi-Jurng, K., Stokes, H., and Hall, R. (1998): Binding of the purified integron DNA integrase IntI1 to integron- and cassette- associated recombination sites. Mol. Micro 2, 477-490. |
[7] | Crump, J. A., Luby, S. P., and Mintz, E. D. (2004): The global burden of typhoid fever. Bull World Health Organ 82, 346-53. |
[8] | Edwards, R. A., Olsen, G. J., and Maloy, S. R. (2002): Comparative genomics of closely related salmonellae. Trends Microbiol 10, 94-9. |
[9] | Everest, P., Wain, J., Roberts, M., Rook, G., and Dougan, G. (2001): The molecular mechanisms of severe typhoid fever. Trends Microbiol 9, 316-20. |
[10] | Farmer, J. (1995): Enterobacteriaceae: Introduction and Identification, pp. 438-449. In P. Murra, B. FS, and M. Pfaller (Eds): Manual of Clinical microbiology,6th edition, American Society for Microbiology., Washington DC. |
[11] | Francis, C. L., Starnbach, M. N., and Falkow, S. (1992): Morphological and cytoskeletal changes in epithelial cells occur immediately upon interaction with Salmonella typhimurium grown under low-oxygen conditions. Mol Microbiol 6, 3077-87. |
[12] | Fierer, J., and Guiney, D. G. (2001): Diverse virulence traits underlying different clinical outcomes of Salmonella infection. J Clin Invest 107, 775-80. |
[13] | Galan, J. E. (1998): Interactions of Salmonella with host cells: encounters of the closest. |
[14] | Galyov, E. E., Wood, M. W., Rosqvist, R., Mullan, P. B., Watson, P. R., Hedges, S., and Wallis, T. S. (1997): A secreted effector protein of Salmonella dublin is translocated into eukaryotic cells and mediates inflammation and fluid secretion in infected ileal mucosa. Mol Microbiol 25, 903-12. |
[15] | Gregorova, D., Pravcova, M., Karpiskova, R., and Rychlik, I. (2002): Plasmid pC present in Salmonella enterica serovar Enteritidis PT14b strains encodes a restriction modification system. FEMS Microbiol Lett 214, 195-8. |
[16] | Chakravortty, D., Hansen-Wester, I., and Hensel, M. (2002): Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J Exp Med 195, 1155-66. |
[17] | Hansen-Wester, I., and Hensel, M. (2001): Salmonella pathogenicity islands encoding type III secretion systems. Microbes Infect 3, 549-59. |
[18] | Hensel, M. (2006): Pathogenesity islands and virulence of Salmonella enterica, pp. 146- 172.In P. Mastroeni, and D. Maskell (Eds): Salmonella infections: Clinical, Immunological and Molecular Aspects, Cambridge University press, Cambridge. |
[19] | Hersh, D., Monack, D. M., Smith, M. R., Ghori, N., Falkow, S., and Zychlinsky, A. (1999): The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci U S A 96, 2396-401. |
[20] | Hobbie, S., Chen, L. M., Davis, R. J., and Galan, J. E. (1997): Involvement of mitogen- activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J Immunol 159, 5550-9. |
[21] | Huckstep, R. L. (1962): Typhoid fever and other Salmonella infections. E&S Livingstone Ltd. Edinburgh and London. |
[22] | Huang, L., Crothers, K., Atzori, C., Benfield, T., Miller, R., Rabodonirina, R., and Helweg-Larsen, J. (2004): Dihydropteroate Synthase Gene Mutations in Pneumocystis and Sulfa Resistance. Emerg Infect Dis 10, 1721-1728. |
[23] | Lalmanach, A. C., and Lantier, F. (1999): Host cytokine response and resistance to Salmonella infection. Microbes Infect 1, 719-26. |
[24] | Langridge, G., Nair, S., and Wain, J. (2008): Invasive Salmonellosis in Humans. In R. C. I. A. Böck, J. B. Kaper, F. C. Neidhardt, T. Nyström, K. E. Rudd, and C. L. Squires (Ed.): EcoSal-Escherichia coli and Salmonella:cellular and molecular biology, ASM Press, Washington, D.C.. |
[25] | Liebana, E. (2002): Molecular tools for epidemiological investigations of S. enterica subspecies enterica infections. Research in Veterinary Science 72, 169-175. |
[26] | Lewis, M. (1998): Salmonellae: Food poisoning: enteric fever, pp. 253-261: A guide to microbial infection: Pathogenesis, Immunology, Laboratory diagnosis and Control,1st ed., Addison Wesley, China. |
[27] | Looney, R. J., and Steigbigel, R. T. (1986): Role of the Vi antigen of Salmonella typhi inresistance to host defense in vitro. J Lab Clin Med 108, 506-16. |
[28] | Jacoby, G. A. (2005): Mechanisms of resistance to quinolones. Clin Infect Dis 41 Suppl 2, S120-6. |
[29] | Jacoby, G. A., and Medeiros, A. A. (1991): More extended-spectrum beta-lactamases. Antimicrob Agents Chemother 35, 1697-704. |
[30] | Parry, C. M., Hien, T. T., Dougan, G., White, N. J., and Farrar, J. J. (2002): Typhoid fever. N Engl J Med 347, 1770-82. |
[31] | Parry, C. M. (2003): Antimicrobial drug resistance in Salmonella enterica. Curr Opin Infec Dis 16, 467-72. |
[32] | Popoff, M. Y., Bockemuhl, J., and Brenner, F. W. (1998): Supplement 1997 (no. 41) to the Kauffmann-White scheme. Res Microbiol 149, 601-4. |
[33] | Popoff, M. Y., Bockemuhl, J., and Gheesling, L. L. (2004): Supplement 2002 (no. 46) to the Kauffmann-White scheme. Res Microbiol 155, 568-70. |
[34] | Rychlik, I., Gregorova, D., and Hradecka, H. (2006): Distribution and function of plasmids in Salmonella enterica. Vet Microbiol 112, 1-10. |
[35] | Selander, R. K., Beltran, P., Smith, N. H., Helmuth, R., Rubin, F. A., Kopecko, D. J., Ferris, K., Tall, B. D., Cravioto, A., and Musser, J. M. (1990): Evolutionary genetic relationships of clones of Salmonella serovars that cause human typhoid and other enteric fevers. Infect Immun 58, 2262-75. |
[36] | Schwarz, S., and Chaslus-Dancla, E. (2001): Use of antimicrobials in veterinary medicine and mechanisms of resistance. Vet Res 32, 201-25. |
[37] | Schwarz, S., Kehrenberg, C., Doublet, B., and Cloeckaert, A. (2004): Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol Rev 28, 519-42. |
[38] | Su, L. H., Chiu, C. H., Chu, C., and Ou, J. T. (2004): Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infect Dis 39, 546-51. |
[39] | Su, L. H., Chiu, C. H., Chu, C., Wang, M. H., Chia, J. H., and Wu, T. L. (2003): In vivo acquisition of ceftriaxone resistance in Salmonella enterica serotype anatum. Antimicrob Agents Chemother 47, 563-7. |
[40] | Sturenburg, E., and Mack, D. (2003): Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 47, 273-95. |
[41] | Tassios, P. T., Markogiannakis, A., Vatopoulos, A. C., Katsanikou, E., Velonakis, E. N., Kourea-Kremastinou, J., and Legakis, N. J. (1997): Molecular epidemiology of antibiotic resistance of Salmonella enteritidis during a 7-year period in Greece. J Clin Microbiol 35, 1316-21. |
[42] | Taylor, D. E., and Brose, E. C. (1985): Characterization of incompatibility group HI1 plasmids from Salmonella typhi by restriction endonuclease digestion and hybridization of DNA probes for Tn3, Tn9, and Tn10. Can J Microbiol 31, 721-9. |
[43] | Mastroeni, P. (2002): Immunity to systemic Salmonella infections. Curr Mol Med 2, 393- 406. |
[44] | Mastroeni, P. (2006): Mechanisms of immunity in Salmonella infection, pp. 207-254. In P. Mastroeni, and D. Maskell (Eds): Salmonella infections: Clinical, Immunological and Molecular aspects, Cambridge University press, Cambridge. |
[45] | Mastroeni, P., Vazquez-Torres, A., Fang, F. C., Xu, Y., Khan, S., Hormaeche, C. E., and Dougan, G. (2000): Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med 192, 237-48. |
[46] | McClelland, M., Sanderson, K. E., Spieth, J., Clifton, S. W., Latreille, P., Courtney, L., Porwollik, S., Ali, J., Dante, M., Du, F., Hou, S., Layman, D., Leonard, S., Nguyen, C., Scott, K., Holmes, A., Grewal, N., Mulvaney, E., Ryan, E., Sun, H., Florea, L., Miller, W., Stoneking, T., Nhan, M., Waterston, R., and Wilson, R. K. (2001): Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413, 852-6. |
[47] | Mizuno, Y. (2004): [Host defense mechanisms against Salmonella infection]. Nihon Rinsho Meneki Gakkai Kaishi 27, 367-72. |
[48] | Miriagou, V., Tassios, P. T., Legakis, N. J., and Tzouvelekis, L. S. (2004): Expanded- spectrum cephalosporin resistance in non-typhoid Salmonella. Int J Antimicrob Agents 23, 547-55. |
[49] | McQuiston, J. R., Parrenas, R., Ortiz-Rivera, M., Gheesling, L., Brenner, F., and Fields, P. I. (2004): Sequencing and comparative analysis of flagellin genes fliC, fljB, and flpA from Salmonella. J Clin Microbiol 42, 1923-32. |
[50] | Winokur, P. L., Canton, R., Casellas, J. M., and Legakis, N. (2001): Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 32 Suppl 2, S94-103. |
[51] | Van Asten, A. J., and van Dijk, J. E. (2005): Distribution of "classic" virulence factors among Salmonella spp. FEMS Immunol Med Microbiol 44, 251-9. |
[52] | Michael, C., Gillings, M., and Holmes, A. (2004): Mobile gene cassettes: a fundamental resource for bacterial evolution. The American Naturalist 164, 1-12. |
[53] | Winokur, P. L. (2003): Molecular epidemiological techniques for Salmonella straindiscrimination. Front Biosci 8, c14-24. |
[54] | Winokur, P. L., Brueggemann, A., DeSalvo, D. L., Hoffmann, L., Apley, M. D., Uhlenhopp, E. K., Pfaller, M. A., and Doern, G. V. (2000): Animal and human multidrug- resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Antimicrob Agents Chemother 44, 2777-83. |
[55] | Winokur, P. L., Canton, R., Casellas, J. M., and Legakis, N. (2001): Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 32 Suppl 2, S94-103. |